Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

REAl-world Outcomes in CHronic Lymphocytic Leukemia Patients Receiving Acalabrutinib in Romania

NCT06170671

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Research Site Piteşti, Argeş, Romania
  • Research Site Oradea, Bihor County, Romania
  • Research Site Cluj-Napoca, Cluj, Romania
  • Research Site Craiova, Dolj, Romania
View all 19 locations
View Trial Details
Active, Not Recruiting

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia

NCT01841723

Conditions
Hairy Cell Leukemia, Hairy Cell Leukemia Variant, Hematologic Diseases, +11 more
Locations
  • National Institutes of Health Clinical Center Bethesda, Maryland, United States
  • Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab + Lenalidomide (+Len), and the Safety, Tolerability, and Pharmacokinetics of SC Versus IV Mosunetuzumab + Len in Participants With Follicular Lymphoma

NCT04246086

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of Miami Miller School of Medicine Miami, Florida, United States
  • Norton Cancer Institute - St. Matthews Louisville, Kentucky, United States
  • Mary Bird Perkins Cancer Ctr Baton Rouge, Louisiana, United States
View all 26 locations
View Trial Details
Active, Not Recruiting

A Study of Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation

NCT03556332

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • University of Alabama Comprehensive Cancer Center Birmingham, Alabama, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)

NCT03213704

Conditions
Advanced Malignant Solid Neoplasm, Central Nervous System Neoplasms, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +83 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 124 locations
View Trial Details
Active, Not Recruiting

Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma

NCT03117751

Conditions
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma, Hematologic Diseases, +11 more
Locations
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Rady Children's Hospital San Diego San Diego, California, United States
  • Children's Hospital of Illinois at OSF-Saint Francis Medical Center (St. Jude Midwest Affiliate - Peoria) Peoria, Illinois, United States
  • Children's Hospital of Michigan Detroit, Michigan, United States
View Trial Details

Related conditions